Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Immune Durability After Vaccination With the Vesicular Stomatitis Virus-vectored Zaire Ebola Candidate Vaccine (VSV-EBOV): a Prospective Observational Cohort Study

NCT02933931 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT02933931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02933931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Immune Durability After Vaccination With the Vesicular Stomatitis Virus-vectored Zaire Ebola Candidate Vaccine (VSV-EBOV): a Prospective Observational Cohort Study
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Completed
Start date
November 30, 2016
Completion date
January 31, 2020
Enrollment
95 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

durability, immune response, vaccination